These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6835560)

  • 1. [Use of calcitonin in neoplastic osteolysis].
    Pastorino G; Bianucci M
    Minerva Med; 1983 Mar; 74(13):707-14. PubMed ID: 6835560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
    Simone C; Racanelli A
    Clin Ter; 1981 Aug; 98(3):247-67. PubMed ID: 7285537
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hypercalcemia in osteolytic metastases with oral amino-hydroxypropylidene-diphosphonate].
    Tubiana-Hulin M; de Vernejoul MC; Brière M; Miravet L; Clavel B
    Presse Med; 1984 Feb; 13(8):483-6. PubMed ID: 6230630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone targeting agents: bisphosphonates].
    Debiais F
    Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD; Charhon SA; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical use of calcitonin in the treatment of osseous localizations in breast carcinoma and multiple myeloma].
    Di Benedetto G; Corsini G; Puppo F; Zavarise GM
    Clin Ter; 1981 Mar; 96(6):605-13. PubMed ID: 7285526
    [No Abstract]   [Full Text] [Related]  

  • 7. Conventional radiograms for assessment of salm-calcitonin therapy for bone metastases from breast carcinoma.
    Geyer J; Quadt C; Perlick E; Starke K; Stier G; Tanneberger S
    Eur J Radiol; 1991; 12(2):124-6. PubMed ID: 2036999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Salmon calcitonin in supportive therapy of neoplastic osteolysis. Preliminary report on a case of myeloma].
    Andriani A; Beni A; Beni RA; Calistri A; Gelli GF
    Clin Ter; 1981 Jan; 96(2):183-91. PubMed ID: 7237953
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monostotic osteolytic metastases].
    Ottolenghi G; Oggero P; Alessi GC
    Minerva Med; 1985 Nov; 76(43):2059-65. PubMed ID: 3934594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
    de Vernejoul MC
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
    [No Abstract]   [Full Text] [Related]  

  • 11. Salmon calcitonin in the treatment of bone metastases.
    Serdengeçti S; Serdengeçti K; Derman U; Berkarda B
    Int J Clin Pharmacol Res; 1986; 6(2):151-5. PubMed ID: 3721646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
    N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
    van Breukelen FJ; Bijvoet OL; van Oosterom AT
    Lancet; 1979 Apr; 1(8120):803-5. PubMed ID: 86043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone metastases from breast cancer treated with calcitonin. Case report.
    Favini G; Arosio A; Libretti A
    Tumori; 1979 Dec; 65(6):713-7. PubMed ID: 543014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of Clodronate in the treatment of bone metastasis].
    Pouillart P; Beuzeboc P
    Bull Cancer; 1991; 78(8):737-41. PubMed ID: 1834287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The analgesic effect of calcitonin on breast cancer patients with bone metastases].
    Kimura M; Abe R
    Gan No Rinsho; 1987 Jul; 33(8):921-7. PubMed ID: 3613114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human calcitonin and malignant osteolysis.
    Nuti R; Righi G; Turchetti V; Vattimo A; Lazzaretto R; Martini G
    Panminerva Med; 1986; 28(1):5-9. PubMed ID: 3960585
    [No Abstract]   [Full Text] [Related]  

  • 18. Agents affecting osteolysis in patients with breast cancer.
    Coombes RC; Neville AM; Gazet JC; Ford HT; Nash AG; Baker JW; Powles JT
    Cancer Chemother Pharmacol; 1979; 3(1):41-4. PubMed ID: 161206
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumorous osteopathy and tumorous hypercalcemia].
    Thiébaud D; Burckhardt P
    Internist (Berl); 1990 Dec; 31(12):756-62. PubMed ID: 2289865
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.